AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2018
Jun 11, 2018
35599_dirs_2018-06-11_8996c24c-46a9-45ea-a65a-1ee27a3ea241.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2018-06-08
Reporting Person: Brughera Marco Maria (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-06-08 | Stock Option (right to buy) | $10.93 | A | 20000 | Acquired | 2025-06-08 | Common Shares (20000) | Direct |
Footnotes
F1: On June 8, 2018, Marco M. Brughera was granted an incentive stock option to purchase 20,000 common shares of the Issuer pursuant to the Issuer's Amended and Restated Stock Option Plan. The option is 100% vested on the date of grant.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20